Ji H. Kwon
Cheongju-si, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Pembrolizumab for Patients with Relapsed or Refractory Extranodal NK/T-Cell Lymphoma in Korea.
Journal: Cancer research and treatment
Published: September 13, 2023
Prestroke Glucose Control and Functional Outcome in Patients With Acute Large Vessel Occlusive Stroke and Diabetes After Thrombectomy.
Journal: Diabetes care
Published: February 01, 2021
Limited benefits of thalidomide and dexamethasone maintenance after autologous stem cell transplantation in newly diagnosed multiple myeloma patients: a prospective phase II multi-center study in Korea.
Journal: Current problems in cancer
Published: December 14, 2020
Real-world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis.
Journal: Cancer communications (London, England)
Published: October 20, 2020
Hyperthermia Disturbs and Delays Spontaneous Differentiation of Human Embryoid Bodies.
Journal: Biomedicines
Published: May 11, 2020
Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial Tumors.
Journal: Frontiers in oncology
Published: May 25, 2019
MiR-9 Controls Chemotactic Activity of Cord Blood CD34⁺ Cells by Repressing CXCR4 Expression.
Journal: International journal of stem cells
Published: July 24, 2018
Infectious complications in multiple myeloma receiving autologous stem cell transplantation in the past 10 years.
Journal: International journal of hematology
Published: February 06, 2017
No benefit of hypomethylating agents compared to supportive care for higher risk myelodysplastic syndrome.
Journal: The Korean journal of internal medicine
Published: December 21, 2016
Clinical outcome and efficacy of current anti-leukemic therapy for leptomeningeal involvement in acute myeloid leukemia.
Journal: International journal of hematology
Published: January 26, 2016
Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study.
Journal: Haematologica
Published: November 23, 2015
Last Updated: 09/26/2026